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Preservation of macronutrient preferences in cancer
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Summary Indirect evidence suggests that cancer anorexia is associated with specific aversions to macronutrients. To investigate this,
patients with cancer anorexia and hospitalized control subjects devised 3-day menus comprising foods that they wished to eat. These foods
were then provided for 3 days and the intakes of each food carefully measured. As expected, patients with cancer anorexia consumed
substantially less energy than hospitalized control subjects (6.0 ± 0.9 MJ vs 9.5+0.5 MJ, P < 0.001). However. macronutrient composition was
consistently maintained in the patients with cancer anorexia. These data argue against cancer anorexia representing a state of macronutrient
aversion.
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Anorexia is a major component of cancer cachexia (Brennan.
1977: DeWxs. 1980: Hvltander et al. 1993: Nelson et al. 1994).
Indirect evidence from animal studies and from patients with
cancer cachexia undergoing chemotherapy or radiotherapy
suggests that in cancer anorexia preferences for macronutrients
(fat. carbohydrate and protein) may become altered (McCarthy-
Leventhal. 1959: DeWNs. 1974: Carson and Gormican. 1977:
Bernstein. 1978: Bernstein and Sigmundi. 1980 Levine and
Emery. 1987: Cangiano et al. 1996). The paucity of prospective.
accurate data on macronutrient preferences in patients with cancer
anorexia reflects the extreme difficulty in conducting such studies.
We undertook to investigate. directly. dietary intake and macro-
nutrient preferences in patients with cancer anorexia. who were
allowed to select freely the nature. quantity and frequency of the
foods that thev ate.
SUBJECTS AND METHODS
Subjects
Ten patients Aith cancer anorexia were recruited from two
oncology wards. Cancer anorexia was defined by the presence of
diminished appetite in patients with histologically confirmed
malignancy. and greater than 15% wleight loss over 12 months.
Twent grender-matched controls were recruited from three general
medical shards. All patients who were approached over the
6-month study period agreed to participate in the study and
provided informed consent.
Patients were excluded ifaged over 70 years. showed evidence
of malabsorption. were unable to take or retain oral nourishment.
followed a restricted diet or were unstable clinically. Patients with
malignancy were excluded ifthey had undergone chemotherapy or
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radiotherapy within 4 months before the study. The study was
performed in accordance with the requirements ofthe institutional
ethics committee.
The nutritional status of the patients was assessed from
measurements of weight. height. calculation of body mass index
(BMI: weight/height'). detennination ofpercentage body fat using
four-site skinfold thickness measurements (Holtain. UK) (Durnin
and Rahaman. 1967) and calculation of mid-arm muscle circum-
ference (MAMC) (Bistrian et al. 1976).
Assessment of dietary intake
At the beginning of the study. patients were given a list of 200
foods and asked to devise a 3-day menu for themselves. Food
options varied widely and included fresh foods. foods from a
variety of cultural origins. snack foods as well as simply prepared
foods such as eags or toast. A vaniet of hot and cold beverages
were available. Patients were able to identify optimal portion sizes
and to select meal times and frequencies.
For the next 3 days. all foods and beverages were provided
according to the patients' choices. Men were provided with a
minimum of 11.7 MJ and 60 g of protein. while women were
provided with a minimum of 10.9 MJ and 55 g of protein: snack
foods and beverages were provided in addition. All meals were
prepared by the same investigator (JAL) in a metabolic kitchen.
Recipes. meal preparation. presentation and temperatures were
standardized. Before presentation all foods. plates and cutlerx
were weighed to + 0.01 a. using the same scales (SD 300T. Sauter.
Germany). Foods remaining after meals were dissected and each
item reweighed: cooking losses were accounted for. Plates and
cutlerv were rew-eiahed before washing. Throughout the study.
patients were sedentary and none took exercise.
A number of precautions were taken to ensure compliance.
Patients were asked to consume only the foods provided. Relatives
and ward staffwere informed ofthis restriction and requested not to
provide additional foods or beverages. Patients gave oral consent
for bedside lockers to be inspected and this was carried out daily.
Notices were posted on patients' beds regarding the limitations of
579Table 1 Demographic data and anthropometric variables in ten patients
with malignant cachexia and 20 hospitalized control patients. Data expressed
as mean + s.e.
Age Weight BMI MAMC Body fat
M:F (years) (kg) (kg m 2) (cm) (%)
Cancercachexia 5:5 55+3 561+4 19+-1 15+2 14-2
Hospitalized controls 10:10 50±+3 67 -2 23-1+1 22-1 25 + 1'
BMI. body mass index; MAMCO mid-arm muscle circumference. Comparison
between patients with cancer anorexia and hospitalized control subjects:
P < 0.001.
Figure 1 Fat, carbohydrate and protein composition in ten patients with
malignant cachexia (-) and in 20 hospitalized controls (=)
Table 2 Dietary intake in ten patients with malignant cachexia and in 20
hospitalized control patients
Cachexia Controls Statistcal
(n = 10) (n = 20) significance
Energy
Total intake (MJ day-) 6.0 0.9 9.5 0.5 P< 0.001
Intake/body weight 0.10 0.01 0.14 0.01 P< 0.005
(MJ day-, Kg-,)
Intake/fat free mass 0.12 0.02 0.19 _ 0.01 P< 0.005
(J Kg-, day-,)
Fat
Total intake (gday-) 70 - 11 117 ± 8 P< 0.005
Intake/body weight (g day- kg-) 1.2 + 0.2 1.8 ± 0.2 P < 0.05
Intake/fat free mass (g kg-, day-) 1.4 ± 0.2 2.4 0.2 P=0.01
Proportion of total energy 0.42 ± 0.02 0.44 + 0.01
Carbohydrate
Total intake (gday-,) 158 +21 246 _ 13 P< 0.001
Intake/body weight (g day-' Kg-') 2.8 0.4 3.7 ± 0.2 P < 0.05
Intake/fat free mass (g Kg- day-) 3.3 _ 0.4 4.9 + 0.3 P < 0.005
Proportion of total energy 0.45 _ 0.02 0.43 0.01
Protein
Total intake (g day-) 49.4 t 8.0 77.7 + 4.7 P < 0.005
Intake/body weight (g day-' kg-') 0.86 -0.12 1.17 0.07 P< 0.05
Intake/fat free mass (g Kg- day-,) 1.0 t 0.1 1.6 + 0.1 P < 0.005
Proportion of total energy 0.14 - 0.01 0.14 _ 0.01
the study. Patients. relatives. friends and ard staff were questioned
each day to determine whether the patients had consumed foods
other than those prox ided. On day 2 or 3 of the study. patients were
asked to complete a computerized questionnaire detailing the foods
consumed on the previous day. and these data xxere compared with
the foods supplied. On completion ofthe study. patients were asked
to list any foods or beverages that had been consumed without
knowledge ofthe investigators.
The weight of each food eaten was calculated and each food
was analysed for energy. protein. fat and carbohydrate contents
using standard food analysis techniques (FAO. 1986). Mean daily
dietary intakes of energy. protein. fat and carbohydrate for the 3
study day s were calculated.
Power calculations and statistical analysis
Txxo gender-matched controls were recruited for each patient.
Where a = 0.05 and poxxer = 0.9. we estimated that nine patients
ith cancer anorexia and 18 control subjects ould be required to
detect a 6%7 difference in 3-day dietarv fat or carbohydrate (s.d. =
4.5%7c). Similarlx. ten patients with cancer anorexia and 18 control
subjects would be required to detect a 4% difference in
3-dav dietan, protein (s.d. =4.5 %c).
Foods unaccounted for were estimated for each patient. Values
for anthropometric variables and nutrient intakes were compared
between the patient groups using Student's unpaired t-test.
Significance %vas defined as P < 0.05. Data are expressed as
mean ± s.e.
RESULTS
The cancer cachexia group comprised ten malnourished patients
(Table 1) with the followin, malignancies: metastatic breast
adenocarcinoma. multiple myeloma. stage IV non-Hodgkin's
lymphoma. squamous cell lung carcinoma. pancreatic adeno-
carcinoma. metastatic prostate adenocarcinoma. carcinomatosis
(adenocarcinoma)(n = 2). metastatic ovarian adenocarcinoma and
malignant glioma. Admission diagnoses included one or more of
the following: cachexia and/or social incapacity (n = 7). pneu-
monia (n = 3). urosepsis (n = 1). bone pain (n =2). All patients
reported persistent xxeight loss and anorexia. and none reported
amelioration of symptoms before or during the study. Sex-en ofthe
patients received opiate analgesia and three received benzodi-
azepines during the hospitalization.
The hospitalized control group (Table 1) comprised 20 patients
admitted to general medical wards with diagnoses hich included
ischaemic heart disease. urosepsis. asthma pneumonia chronic
obstructive airwaxs disease. biliarv colic. cerebral thrombosis and
myocarditis. Most patients were studied between days 2 and 5 of
their hospitalization: none reported anorexia or recent Aeight loss.
Ten patients received opiate analgesia and three benzodiazepines
during the hospitalization.
Dietary intake
Food losses were less than 1cre of the total xeigaht of food
provided: the coefficient of variation for repeated measures of
food composition was <3%l-. Intakes of energy. fat. carbohydrate
and protein were significantly decreased in the malignant cachexia
group compared with the hospitalized controls. when expressed in
absolute terms and when corrected for nutritional status (Table 2).
When dietary composition was compared between the malignant
cachexia group and the hospitalized controls. the proportions of
fat. carbohydrate and protein were unchanged (Table 2. Figure 1).
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--IDISCUSSION
To determine whether cancer anorexia is associated with altered
macronutrient preferences. patients with cancer anorexia and
hospitalized control subjects were allowed to freely select their
foods for 3 days. These foods were then provided for the patients
and dietary intake was precisely and accurately measured. As
expected. the patients with cancer anorexia were malnourished and
showed 40-60% decreases in energy and absolute macronutrient
intakes. However. the proportions offat. protein and carbohydrate
selected by the patients with cancer anorexia were indistinguish-
able when compared with hospitalized controls without anorexia.
These data do not suggest that cancer anorexia is usually associ-
ated with marked alteration of macronutrient preferences.
There were limitations to our approach. Firstly, we studied a
small group of patients with a variety of malignancies. albeit with
the maximum precision possible. There is no evidence to suagest
that cancer anorexia varies in different malignancies (Laviano et
al. 1996). and a sufficient number of patients was included to
detect physiologically meaningful differences in macronutrient
preferences. Other studies of differences in macronutrient prefer-
ences in other disease have states using less precise methods
(Algere et al. 1995: Bryner et al. 1997) have included fewer
subjects than we did. Secondly. 3 days mav not have been an
adequate measurement period: however. in hospitalized. sedentary
patients. 3 days is sufficient to assess representative dietary intake
(Lee-Han et al. 1989). Thirdly. altered mood was not evaluated as
an independent variable. and a larger study would be required to
assess the impact of this factor on macronutrient preferences in
cancer anorexia. Finally patients do not preselect dietary intake in
the free-living state. Exhaustive effort was made. however. to
provide patients with foods that they wanted. in the quantities they
preferred and at the times and frequencies that they chose.
Although the patients with cancer anorexia we studied exhibited
profound decreases in dietary intake. macronutrient composition
Awas remarkably similar compared with control subjects. This
result was unexpected. In animal models of cancer cachexia.
protein aversion has been detected (Levine and Emery. 1987).
Comparable observations have been made in patients with maliC-
nancies using self-reported questionnaires. although these patients
were receiving chemotherapy or radiotherapy and the assessments
were not performed with the precision employed in this study
(McCarthv-Levethal. 1959: DeWys. 1974: Carson and Gormican.
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1977: Bernstein. 1978: Bernstein and Sisamundi. 1980). The
patients we studied were not receiving chemotherapy or radio-
therapy and were allowed to select their foods freely. so that the
measurements we made were likely to represent true macro-
nutrient preferences. In conclusion. this studv refutes the
contention that cancer anorexia is associated with altered
macronutrient preferences.
REFERENCES
Alger S. S-eagle H and Ravussin E 199IW Food intake and energ- expenditure in
obese female bingers and non-bingers. Int J Obes Related Aterab Dis 19: 11-16
Bernstein IL (19781 Learned taste aversions in children receiving chemotherapy.
Science 200: 1302-1303
Bernstein IL and Sirmundi RA (19801 Tumor anorexia - a learned food aversion'
Science 209: 416-418
Bistrian BR. Blackburn GL. V-itale J et al 1976 Prevalence of malnutrition in
general medical patients. JAM.4 235: 1567-1570
Brennan MF 1977 Uncomplicated starvation versus cancer cachexia. Cancer Res
37: 2359-2364
Brvner RA. Toffle RC. UlLrich IH et al (1997 The effec-ts of exercise intensitr on
body composition. weight loss. and dietan composition in %%omen. J Am Coll
\%utr 16: 68-73
Canaiano C. Laviano A. 'Muscaritoli MI et al (19961 Cancer anorexia: nes
pathogenic and therapeutic insights. Nutrition 12: S48- 51
Carson JA and Gormican A (19771 Taste acuitv and food attitudes of selected
patients with cancer. JAm Diet.Assoc 70: 361-365
DeAVys WD (19741 A spectrum oforgan systems that respond to the presence of
cancer. Abnormalities oftaste as a remote effect of a neoplasm. .Ann N Y-Acad
Sci 230: 427-434
De%s A-D. Begg C. Lavin PT et al ( 19801 Prognostic effect of Aeight loss prior to
chemotherapy in cancer patients. Am JMed69: 491-49
Durnin JVGA and Raharnan MM 1967 The assessment of the amount of fat in the
human bodv from measurements of skinfold thickness. Br JN-utr 21: 681-689
FAO (19861 Manuals offood quality control. Food anals sis: general techniques.
additises. contaminants. and composition. Fod.Nutr 14': 1-159
Hyvltander A. Komner U and Lundholm KG (1993 Evaluation of mechanisms behind
elevated energy expenditure in cancer. Eur J Clin Invest 23: 46-52
Laviano A. Meauid MM. Yan2 ZJ et al (19961 Cracking the riddle of cancer
anorexia. Nutrition 12: 706-710
Lee-Han H. McGuire V and Bovd NF (19891 A revies of the methods used b!
studies of dietarn measurement. J Clin Epidemiol 42: 269-279
Levine JA and Emen- PW (19871 The sienificance of learned food aversions in the
aetiolo-e of anorexia associated w-ith cancer. BrJ Cancer 56: 7378
McCarthyv-Leventhal EM (19591 Postradiation mouth blindness. Lancet 2:
1138-1139
Nelson KA. Walsh D and Sheehan FA 19941 The cancer anorexia-cachexia
s-ndrome. J Clin Oncol 12: 21I 22"
British Journal of Cancer (1998) 78(5). 579-581